top of page

Oxalo

THERAPEUTICS

Media Features

Oct 15, 2019

Oxalo co-founder Dr. Hatim Hassan named a Illinois Researchers to Know 2019

May 10, 2019

Oxalo co-founder Yang Zheng named Crain's 20 in Their 20s

October 17, 2018

Oxalo is awarded $75K as a Platinum Winner at MassChallenge

September 25, 2018

Crain's: UChicago startup gets $2.3M for kidney stone prevention drug

September 24, 2018

ChicagoInno: UChicago biotech gets $2.3M from NIH, makes MassChallenge Finals

August 15, 2018

Oxalo amongst two high-impact UChicago team participating in MassChallenge

August 9, 2018

Oxalo Therapeutics receives rare disease scholarship and support from Cydan

June 21, 2018

Oxalo Therapeutics featured in Crain's Chicago Business

May 31, 2018

Oxalo Therapeutics awarded $25K as a Finalist in the New Venture Challenge, the #1 ranked university accelerator

May 28, 2018

Oxalo Therapeutics featured in Edgy Labs, driving research from the lab into the real world

May 24, 2018

Oxalo Therapeutics featured in BioSpace, MBA student and scientist form promising startup

May 23, 2018

Oxalo Therapeutics is accepted into the most competitive and diverse cohort of MassChallenge Boston

May 18, 2018

Oxalo Therapeutics - a look into the company's move from basic research to a funded venture

May 2, 2018

Oxalo Therapeutics speaks about research university-driven innovation

January 26, 2018

Oxalo Therapeutics utilizes knowledge of the microbiome to prevent kidney stones

December 6, 2017

Oxalo Therapeutics raises $250K from the Innovation Fund

Oxalo

THERAPEUTICS

At Oxalo, we are committed to developing innovative therapies for patients with severe and rare kidney diseases caused by oxalate.

Oxalo Therapeutics, Inc.

Polsky Exchange

1452 E. 53rd St, 2nd Floor

Chicago, IL 60615

bottom of page